Course Title: CE Workshop 05 - Introduction to the Neuropsychology of COVID-19 (Cysique/Lojek)


Credit Hours: 1.5


Instructor(s) Lucette Cysique; Emilia Lojek


Lucette Cysique, PhD
Senior Research Fellow, UNSW Psychology
Faculty of Science, Sydney, Australia
Senior researcher
St. Vincent’s Hospital Centre for Applied Medical Research, Sydney, Australia
Visiting scholar
St. Michael’s Hospital, Toronto, Canada
Senior researcher
The Alfred Hospital Melbourne, Australia
and
Emilia Łojek, PhD
Full Professor
Faculty of Psychology
University of Warsaw, Poland

CE Workshop # 5:


Introduction to the Neuropsychology of COVID-19

Abstract & Learning Objectives:

The workshop will be organized around three critical areas as related to COVID-19. First, the presenters will review up-to-the minute knowledge on COVID-19 as related to cognitive and brain functioning including definitions and concepts, epidemiology, neurological consequences of COVID-19, neuroinvasion and pathogenesis of SARS-COV-2 and associated comorbidities. Second, we will present the gained neuropsychological knowledge since the start of the pandemic. This will include pervious neuropsychological research on conditions associated with COVID-19 illness (e.g., acute respiratory distress syndrome, stroke, encephalitis, ICU cognitive sequalae) and closely related viruses (SARS, MERS). Neuropsychological research specifically on COVID-19 will include case presentation and preliminary results of ongoing studies. Third, the presenters will provide an overview of the NeuroCOVID INS SIG recommendations for the evaluation of patients with COVID-19. These recommendations take onto account the phases of the disease, including the patient’s infectious stage, the spectrum of possible neuropsychological disorders in COVID-19 and its severity levels (asymptomatic to very severe), the longitudinal dynamic of the illness and considerations regarding cross-cultural, demographics, mental health status, comorbidities, psychological and social factors.


Upon conclusion of this course, learners will be able to:

  • Describe the current state of the knowledge on COVID-19 as related to cognitive and brain functioning
  • Critique the level of gained neuropsychological knowledge since the beginning of the pandemic
  • Discuss the recommendations for neuropsychological research and clinical practice for the assessment of COVID-19 patients

Speaker Biography:

Dr. Lucette Cysique is a neuropsychologist, who has led a research program in NeuroHIV, neuropsychology and neuroimaging at the University of New South Wales (UNSW), Sydney, Australia since 2009. She conducts cross-disciplinary research into the neurocognitive and brain changes associated with HIV and aging, HIV and cardiovascular diseases, and HIV and mental health. She has extensive experience in cross-cultural neuropsychology as applied to HIV infection and contributes to the development of normative neuropsychological data for cross-sectional and longitudinal studies. Dr. Cysique is currently employed as a Senior Lecturer at UNSW Psychology via a visiting scholar support from Li Ka Shing Knowledge Institute, St. Michael’s Hospital (University of Toronto affiliated Institute, Ontario, Canada) and support from the Sydney St. Vincent’s Hospital Applied Medical Research Centre in the Applied Neuroscience Unit, as well as support from the Melbourne Alfred Hospital Burnett Institute. She is also an Academic Consultant at the Missouri Institute of Mental Health (University of Missouri Saint Louis, MO, USA). She is co-chair of the NeuroCOVID-19 INS SIG, and she is currently involved in several studies in Sydney Australia, which aims are to assess the potential neurocognitive, perceptual (smell and taste) and mental health complications of COVID-19.

Dr. Emilia Łojek is a Full Professor at the Faculty of Psychology, University of Warsaw (UW), Poland. She completed M.A., Ph.D. and further scientific degrees in psychology and neuropsychology at the UW. As a Fellow of the British Council, the Ginsberg’s, the EU TEMPUS and the Kosciuszko Foundations she also extended her studies in neuropsychology at University of Cambridge, UK, National Hospital’s College of Speech Sciences London, UK and Ohio State University, USA. She has served as Director of Warsaw International Studies in Psychology at UW and has a record of leadership in the Commissions of the Polish Neuropsychological Society and the Polish Academy of Sciences. She was honoured to be the INS Board of Governors Member (2014-2017), Chair of INS Social Media Committee (currently) and co-chair of the INS NeuroCovid SIG.
She has published 12 books, over 100 research articles and chapters on a wild range of topics ranging from communication disorders in brain damaged patients, neuropsychological changes in neurodegenerative and psychiatric diseases to the stability of neurocognitive patterns in HIV infection. She has been involved in the Neuropsychology Research Program: HIV Drug and Alcohol Studies at the OSU. Recently she conducted the international research program on the effect of aging on cognitive and chemosensory functions in HIV infected individuals. As an author or co-author she has adapted and standardized in Polish Neuropsychological tests (H-RNTB, RHLB, RFFT, CVLT, CTT, CTT-C, BDI-II_PL) and was the main author of the Depression Questionnaire (KPD) and the RHLB-PL for Children. She was a guest co-editor of the Clinical Neuropsychologist Special Issue (2019): Are modern neuropsychological assessment methods really “modern? She is currently co-charing the INS NeuroCovid-19 SIG. She has received national awards for her scientific achievements (Copernicus Price 2011, 2017) and the INS Paul Satz Mentoring Award (2018).